Matthew Plunkett

Matthew J.
Plunkett formerly worked at CIBC World Markets Corp., as Managing Director from 2008 to 2009, CTI BioPharma Corp., as Chief Business Officer & Executive Vice President from 2015 to 2017, Oppenheimer & Co., Inc., as MD & Head-West Coast Biotechnology from 2000 to 2009, Sunesis Pharmaceuticals, Inc., as Research Scientist, Axys Advanced Technologies, Inc., as Research Scientist, California Institute for Regenerative Medicine, as Chief Financial Officer from 2011 to 2012, iPierian, Inc., as Chief Financial Officer & Vice President from 2009 to 2011, Imago BioSciences, Inc., as Chief Financial Officer in 2021, Medeor Therapeutics, Inc., as Chief Financial & Business Officer from 2017 to 2018, Nkarta, Inc., as Chief Financial Officer from 2019 to 2020, Apollomics, Inc., as Chief Financial Officer, and Aeovian Pharmaceuticals, Inc., as Chief Financial Officer from 2022 to 2024.
Dr. Plunkett received his undergraduate degree from Harvey Mudd College and doctorate degree from the University of California, Berkeley.